USPTO serial 86846606
ADCAMLA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- EISNACH, MICHAEL PATRICK
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ADCAMLA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John C. Baum
JOHN C. BAUM OWEN, WICKERSHAM & ERICKSON, P.C.455 MARKET STREET, STE. 1910SAN FRANCISCO, CA 94105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATIONS FOR USE IN HUMANS, NAMELY, CHEMOTHERAPEUTICS; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF DISORDERS OF THE NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE CARDIO-VASCULAR SYSTEM, THE METABOLIC SYSTEM, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, AND THE GENITOURINARY SYSTEM; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, AUTOIMMUNE DISEASES, AND INFLAMMATORY DISORDERS; PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY, ONCOLOGY, HEMATOLOGY, OPHTHALMOLOGY, GASTROENTEROLOGICAL DISORDERS, AND TISSUE AND ORGAN TRANSPLANTOLOGY | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 27, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 27, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 15, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 14, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 12, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 30, 2018 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jan 29, 2018 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jan 29, 2018 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jan 29, 2018 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jan 24, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 12, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 10, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 10, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 10, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 24, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 29, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 29, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 9, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 26, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 24, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 24, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 24, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2016 | ALIE | ASSIGNED TO LIE | — |
| Oct 4, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 16, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 15, 2015 | NWAP | NEW APPLICATION ENTERED | — |